Streetbeat News

PODD

Insulet Corporation

https://www.insulet.com

Industry

Medical - Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Open

256.90

Mkt cap

19B

Volume

1.5M

High

275.52

P/E Ratio

45.58

52-wk high

275.52

Low

254.44

Div yield

N/A

52-wk low

152.04

Blue Orca Capital released a report shorting Insulet Corporation (PODD) and favoring EOFlow after a court ruling ended Insulet's injunction against EOFlow, threatening Insulet's monopoly in the automated insulin delivery systems market. The ruling allows competition and could significantly impact Insulet's market position and share price, which is anticipated to drop over 15%. Conversely, EOFlow's stock value is expected to see a resurgence. Insulet had previously reported strong Q1 earnings, but the court's decision introduces uncertainty into its future performance.

Portfolio Pulse from Vandana Singh

May 14, 2024 | 6:44 pm

Wall Street trades flat amid mixed producer inflation data and anticipation for consumer inflation report. Fed Chair Powell sees prolonged current monetary policy, while President Biden imposes significant tariffs on Chinese imports. The U.S. dollar index and Treasury yields fell, while small caps and meme stocks like GameStop and AMC surged. Commodities saw mixed movements, and Bitcoin dropped. Key ETFs and stocks like Insulet, Plug Power, SunPower, and Delcath Systems reacted to various news, including earnings and significant financial developments.

Portfolio Pulse from Piero Cingari

May 14, 2024 | 5:59 pm

Soren Aandahl of Blue Orca Capital recommends shorting Insulet Corporation (PODD) and going long on EOFlow, following a Federal Court of Appeals decision last week that terminated a preliminary injunction protecting Insulet's monopoly against EOFlow.